Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
Donald Trump
Kamala Harris
US Open
NFL
Volleyball
US Economy
US Politics
Republican Party
School Shooting
US Crime
US Immigration
Department of Justice
Get access to our best features
Get Started
Published

28 Million Obese Patients Are Expected To Be On GLP-1 Drugs By 2029

Summary by Wccftech
In what substantially bolsters the veracity of the tagline that the GLP-1 anti-obesity drugs constitute one of the most compelling cases of thematic investing this decade, UBS is out today with a fresh investment note that illustrates the scale of this ongoing paradigm shift in how the healthcare industry deals with the persistent obesity pandemic. The GLP-1 hormone suppresses hunger and regulates the production of insulin and glucose. After a m…

0 Articles

All
Left
Center
Right
WccftechWccftech

28 Million Obese Patients Are Expected To Be On GLP-1 Drugs By 2029

In what substantially bolsters the veracity of the tagline that the GLP-1 anti-obesity drugs constitute one of the most compelling cases of thematic investing this decade, UBS is out today with a fresh investment note that illustrates the scale of this ongoing paradigm shift in how the healthcare industry deals with the persistent obesity pandemic. The GLP-1 hormone suppresses hunger and regulates the production of insulin and glucose. After a m…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Novo NordiskNovo Nordisk
Eli LillyEli Lilly
UBSUBS

You have read 0 out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal